(0.27%) 5 194.98 points
(0.14%) 38 905 points
(0.23%) 16 386 points
(-0.04%) $78.45
(0.82%) $2.21
(-0.41%) $2 321.60
(-0.33%) $27.52
(2.27%) $986.80
(0.04%) $0.929
(0.52%) $10.88
(0.24%) $0.798
(-1.15%) $90.30
0.00% $ 0.159
Live Chart Being Loaded With Signals
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases...
Stats | |
---|---|
Volumen de hoy | 185 167 |
Volumen promedio | 570 667 |
Capitalización de mercado | 11.63M |
EPS | $0 ( 2024-03-26 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.122 |
ATR14 | $0.0180 (148.76%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-20 | Puretech Health Plc | Buy | 0 | Convertible Note |
2023-06-12 | Puretech Health Plc | Buy | 0 | Convertible Note |
2023-05-26 | Puretech Health Plc | Buy | 43 133 803 | Warrants |
2023-05-26 | Puretech Health Plc | Buy | 0 | Convertible Note |
2023-05-01 | Puretech Health Plc | Buy | 192 307 692 | Warrants |
INSIDER POWER |
---|
99.97 |
Last 86 transactions |
Buy: 269 373 579 | Sell: 26 728 050 |
Volumen Correlación
Gelesis Holdings, Inc. Correlación
10 Correlaciones Más Positivas | |
---|---|
TBI | 0.855 |
VFC | 0.849 |
NBHC | 0.848 |
AFG | 0.839 |
AUD | 0.836 |
HP | 0.832 |
COP | 0.827 |
ETRN | 0.825 |
DVN | 0.822 |
BOC | 0.821 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Gelesis Holdings, Inc. Correlación - Moneda/Commodity
Gelesis Holdings, Inc. Finanzas
Annual | 2022 |
Ingresos: | $25.77M |
Beneficio Bruto: | $-1.79M (-6.95 %) |
EPS: | $-0.790 |
FY | 2022 |
Ingresos: | $25.77M |
Beneficio Bruto: | $-1.79M (-6.95 %) |
EPS: | $-0.790 |
FY | 2021 |
Ingresos: | $11.19M |
Beneficio Bruto: | $1.20M (10.75 %) |
EPS: | $-0.0423 |
Financial Reports:
No articles found.
Gelesis Holdings, Inc.
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico